Sinai Health

L T R I R E S EA R C H E R S R E C E I V E F U N D I N G F O R I N T E R NA T I O NA L WO R K I N EA R L Y C H I L D H OO D D E V E L O P M E N T Dr. Stephen Lye (pictured) and Dr. Stephen Matthews, researchers at the Lunenfeld-Tanenbaum Research Institute, have been awarded funding through the Healthy Life Trajectories (HeLTI), an initiative of the Canadian Institutes of Health Research. While most beneficiaries of the funding were national in scope, Drs. Lye and Matthews are focused internationally, in conjunction with the World Health Organization. Dr. Matthews will look at India to understand how environmental exposures in the preconception period and pregnancy, infancy and childhood, impact health and development in children. In South Africa, Dr. Lye — Mount Sinai Auxiliary Chair in Women's and Infants' Health Research, and Scotiabank Scientist in Child Adolescent Health Research — will test how to improve women's health prior to, and during, pregnancy in order to reduce health challenges experienced by their children later in life. GO L D S TA N DA R D F O R S MA R T C O M M U T E S In December 2017, Sinai Health System received the Smart Commute Gold designation for the first time. It was granted by Smart Commute — a Metrolinx program — based on the Green Sinai Health Committee's active promotion of sustainable commuting options across our hospitals. Only those organizations achieving outstanding results in this area are granted this designation. is accomplishment underscores the organization's longstanding commitment to green initiatives. Jane Merkley (right) — formerly Executive Vice-President, Patient Services and Quality, and Chief Nurse Executive — has taken on an additional role and portfolio: that of Chief Operating Officer, with responsibility for Information Technology and Sinai Health's Sustainability Program. Ms. Merkley's more than three decades of experience span clinical, administrative, executive and professional practice roles. She joined Bridgepoint in 2007 and her leadership helped facilitate the successful amalgamation of Bridgepoint into the wider Sinai Health System. Dr. Miguel Ramalho-Santos (left) has been appointed the Canada 150 Chair in Developmental Epigenetics — one of four Canada 150 Chairs nationally. He is a Harvard-trained researcher newly recruited to the Lunenfeld- Tanenbaum Research Institute. He studies the influence of environmental cues on fetal development and their long-term impacts on adult health. His research holds enormous promise for improving fertility treatments, pregnancy outcomes and women's and children's health. He has also been appointed to the University of Toronto's renowned Department of Molecular Genetics. Dr. Ian Witterick (right) has been re-appointed Chief, Otolaryngology – Head & Neck Surgery. He is considered to be a pioneer in minimally invasive skull surgery and has been serving as Chief since 2012. Dr. Witterick is currently the Chair of the Medical Advisory Committee (MAC), holds the Alex & Simona Shnaider Research Chair in yroid Oncology, and is a Professor and Chair of the Department of Otolaryngology at the University of Toronto. Dr. Jay Wunder (left) has been re-appointed Surgeon-in-Chief, a role he has held since 2006. He is a world-renowned leader in the treatment and research of sarcoma. A surgeon, researcher and educator, he has developed new processes, implemented new clinical pathways and transformed how care is delivered to patients. His leadership of our Renew Sinai redevelopment will result in 19 state-of-the-art operating rooms. He is the inaugural holder of the Rubinoff Gross Chair in Orthopaedic Oncology, and the Leadership Sinai Chair in Surgery. A P P O I N T M E N T S 5

• Cover